Skip to main content
. 2018 Nov 20;8:527. doi: 10.3389/fonc.2018.00527

Figure 5.

Figure 5

TNBC xenograft tumor pO2 responds to paclitaxel + hyperoxygen treatment. Mice bearing TNBC xenograft tumors were treated with periodic hyperoxygenation, 1 h per day (Ox), and/or paclitaxel (Pax) as described in Methods. Data represent mean pO2 values (Mean ± SEM; N = 4) measured at 0, 24, 48, and 72 h after treatment with paclitaxel (Pax), hyperoxygen (Ox), both (Pax + Ox), or no treatment (Control). There is no significant change (p > 0.05) in tumor pO2 in any group, but the Pax + Ox group does trend to have a higher pO2 24 h after treatment.